ACOPY (ACOPY) Stock Price & Analysis
ACOPY (ACOPY) rose 0.26% to USD 3.83 as of June 10, 2026 at 03:44 UTC, according to Nexqual real-time market data.
ACOPY last closed at USD 3.82; the session ranged USD 3.83–3.83 on volume of 1,000 shares. Market capitalization is $2.78B, with a 52-week range of USD 3.8–6.78 (PNK). Source: Nexqual, June 10, 2026 at 03:44 UTC.
Key Statistics (as of June 10, 2026 at 03:44 UTC)
| Price | USD 3.83 |
|---|---|
| Change | ▲ 0.26% (up) |
| Previous Close | USD 3.82 |
| Open | USD 3.83 |
| Day Range | USD 3.83 – 3.83 |
| 52-Week Range | USD 3.8 – 6.78 |
| Volume | 1,000 shares |
| Market Cap | $2.78B |
| Exchange | PNK |
Technical Analysis (ACOPY)
Nexqual's technical model rates ACOPY "SELL" based on 2 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 03:44 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 7.1 (oversold) |
| vs SMA50 | Below (USD 5.04) |
| MACD | -0.36 (negative) |
Analyst Ratings (ACOPY)
Wall Street analysts rate ACOPY "None", per Nexqual as of June 10, 2026 at 03:44 UTC.
| Consensus Rating | None |
|---|
Earnings (ACOPY)
Source: Nexqual, June 10, 2026 at 03:44 UTC.
Financials & Fundamentals (ACOPY)
| Total Revenue | $2.06B |
|---|---|
| Revenue Growth (YoY) | +18.80% |
| Gross Margin | +45.86% |
| Operating Margin | +14.74% |
| Profit Margin | +5.94% |
| ROE | +14.72% |
| Debt / Equity | 1.38 |
| Current Ratio | 2.96 |
| Total Cash | $896.88M |
| Total Debt | $19.15M |
| Free Cash Flow | $157.61M |
Source: Nexqual, June 10, 2026 at 03:44 UTC.
Financial Health Score (ACOPY)
Nexqual rates ACOPY's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 03:44 UTC.
| Growth | Solid — Revenue +14% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 46%, operating 15% |
| Balance Sheet | Strong — $897M cash vs $19M debt, net cash position |
| Cash Flow | Solid — FCF $158M, 8% margin |
| Efficiency | Mixed — ROE 15%, ROA 9.0% |
Ownership (ACOPY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 725.43M |
| Float | 723.05M |
Source: Nexqual, June 10, 2026 at 03:44 UTC.
Leadership (ACOPY)
ACOPY is led by David L. Bortolussi B.Com., BComm, F.C.A., FFin (age 56), MD, CEO & Director, per Nexqual as of June 10, 2026 at 03:44 UTC.
| MD, CEO & Director | David L. Bortolussi B.Com., BComm, F.C.A., FFin (age 56) |
|---|---|
| Chief Financial Officer | David Muscat BComm, CA (age 46) |
| Chief Marketing Officer | Helena He |
| Managing Director of USA | Kevin Bush |
| Managing Director of International | Yohan Senaratne |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ACOPF | A2 Milk Co Ltd. | USD 5 | ▲ 26.58% |
| ADRZY | Andritz AG | USD 17.53 | ▼ 2.39% |
| BICEY | BIC SA | USD 31.74 | ▼ 0.94% |
| BKFKF | Bakkafrost PF | USD 48.5 | ▲ 5.43% |
| SALRY | Salmar ASA | USD 13.62 | ▼ 3.13% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:44 UTC. This page is informational and not investment advice.